SEC Form 3 · accession 0000875320-26-000270
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jasper van Grunsven
Officer — EVP, CP and NPPO
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney